Consolidated Statements of Operations - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Gross Sales	$ 37,122,215	$ 47,332,085
Allowances	(1,718,991)	(2,851,322)
Total Net Sales	35,403,224	44,480,763
Cost of sales	13,066,639	14,495,063
Gross Profit	22,336,585	29,985,700
Operating expenses	39,647,130	49,601,690
Impairment of goodwill and other intangible assets	60,955,970	0
Loss from operations	(78,266,515)	(19,615,990)
Realized and Unrealized gain (loss) on marketable and other securities, including impairments	(33,350)	546,878
Gain on extinguishment of debt	0	1,466,113
Gain on sale of assets	88,769	0
Restructuring expense	(602,092)	0
Decrease (increase) of contingent liability	8,473,999	(6,687,439)
Other income	239,250	29,479
Interest expense	16,246	(28,930)
Loss before provision for income taxes	(70,083,693)	(24,289,889)
Benefit for income taxes	0	895,000
Net Loss	(70,083,693)	(23,394,889)
Preferred dividends	4,002,005	2,554,609
Net Loss available to cbdMD, Inc. common shareholders	$ (74,085,698)	$ (25,949,498)
Net Loss per share:
Basic earnings per share (in dollars per share)	$ (1.24)	$ (0.47)
Diluted earnings per share (in dollars per share)	$ (1.24)	$ (0.47)
Weighted average number of shares Basic: (in shares)	59,750,301	54,938,128
Weighted average number of shares Diluted: (in shares)	59,750,301	54,938,128